Mahmood Iftekhar, Goteti Kosalaram
Office of Blood Review & Research-OBRR, Center for Biologic Evaluation and Research, Food & Drug Administration, 1401 Rockville Pike, Rockville, MD, USA.
Xenobiotica. 2012 Aug;42(8):756-65. doi: 10.3109/00498254.2012.660210.
The main objective of this work is to evaluate three methods to predict concentration-time data of drugs in humans in a multi-compartment system using animal pharmacokinetic parameters following intravenous administration. The prediction of concentration-time data in humans in a multi-compartment system was based on two proposed methods of Mordenti. The third method was based on the assumption that all drugs follow a single-compartment system. Ten drugs from the literature were chosen that were described by two-compartment model in both human and animals. Two-compartment model parameters (CL, V(c), V(ss), V(β), α, A, β and B) of at least 3 animals were scaled to humans and then were used to predict plasma concentrations-time data in humans. Allometrically scaled pharmacokinetic parameters from animals were also used to predict human profile using one-compartment model as a comparison. The results indicated that in a multi-compartment system, application of pharmacokinetic constants provided better prediction of concentration-time data in humans than the assumption that all drugs follow a single-compartment model. Both the proposed methods of Mordenti provided almost similar concentration-time profiles for most of the drugs. For some drugs, predicted α values were substantially higher than the observed values. This prediction error in α resulted in under-prediction of drug concentrations in distribution phase. In order to reduce the prediction error in α, Waijma's method for the prediction of α was modified which resulted in an improved prediction of concentration-time data in humans. Overall, Mordenti's proposed 2 methods and where necessary by modifying Waijma's method for the prediction of α can be used for reasonably accurate prediction of concentration-time data of drugs in humans.
这项工作的主要目标是评估三种方法,这些方法用于在多室系统中,利用静脉给药后动物的药代动力学参数来预测人体药物浓度-时间数据。多室系统中人体浓度-时间数据的预测基于Mordenti提出的两种方法。第三种方法基于所有药物都遵循单室系统的假设。从文献中选取了10种药物,这些药物在人和动物体内均由二室模型描述。至少3只动物的二室模型参数(CL、V(c)、V(ss)、V(β)、α、A、β和B)按比例换算至人体,然后用于预测人体血浆浓度-时间数据。来自动物的经异速生长比例换算的药代动力学参数也被用于以单室模型作为比较来预测人体情况。结果表明,在多室系统中,应用药代动力学常数比假设所有药物都遵循单室模型能更好地预测人体浓度-时间数据。Mordenti提出的两种方法对大多数药物提供了几乎相似的浓度-时间曲线。对于某些药物,预测的α值显著高于观测值。α的这种预测误差导致分布相中药物浓度预测偏低。为了减少α的预测误差,对Waijma预测α的方法进行了修改,这使得对人体浓度-时间数据的预测得到了改进。总体而言,Mordenti提出的两种方法以及必要时通过修改Waijma预测α的方法,可用于合理准确地预测人体药物浓度-时间数据。